Cargando…

Anti-inflammatory/anti-fibrotic effects of the hepatoprotective silymarin and the schistosomicide praziquantel against Schistosoma mansoni-induced liver fibrosis

BACKGROUND: Praziquantel (PZQ) is an isoquinoline derivative (2-cyclohexylcarbonyl-1, 2, 3, 6, 7, 11b-hexahydro-4H-pyrazino{2,1-a}-isoquinoline-4-one), and is currently the drug of choice for all forms of schistosomiasis. Silymarin, a standardized milk thistle extract, of which silibinin is the main...

Descripción completa

Detalles Bibliográficos
Autores principales:	El-Lakkany, Naglaa M, Hammam, Olfat A, El-Maadawy, Walaa H, Badawy, Afkar A, Ain-Shoka, Afaf A, Ebeid, Fatma A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3398291/ https://www.ncbi.nlm.nih.gov/pubmed/22236605 http://dx.doi.org/10.1186/1756-3305-5-9

Ejemplares similares

Effects of rosuvastatin and/or β-carotene on non-alcoholic fatty liver in rats
por: Seif el-Din, Sayed H., et al.
Publicado: (2015)

Complementary Effect of Capparis Spinosa L. and Silymarin With/without Praziquantel on Mice Experimentally Infected with Schistosoma Mansoni
por: El-Hawary, S. S., et al.
Publicado: (2018)

Effect of Ketoconazole, a Cytochrome P450 Inhibitor, on the Efficacy of Quinine and Halofantrine against Schistosoma mansoni in Mice
por: Seif el-Din, Sayed Hassan, et al.
Publicado: (2013)

A novel praziquantel solid lipid nanoparticle formulation shows enhanced bioavailability and antischistosomal efficacy against murine S. mansoni infection
por: Radwan, Amr, et al.
Publicado: (2019)

Eugenol, a potential schistosomicidal agent with anti-inflammatory and antifibrotic effects against Schistosoma mansoni, induced liver pathology
por: El-kady, Asmaa M, et al.
Publicado: (2019)

Hepatoprotective and Antioxidant Effect of Bauhinia hookeri Extract against Carbon Tetrachloride-Induced Hepatotoxicity in Mice and Characterization of Its Bioactive Compounds by HPLC-PDA-ESI-MS/MS
por: Al-Sayed, Eman, et al.
Publicado: (2014)

Schistosomicidal, hepatoprotective and antioxidant activities of the methanolic fraction from Clerodendrum umbellatum Poir leaves aqueous extract in Schistosoma mansoni infection in mice
por: Jatsa, Hermine Boukeng, et al.
Publicado: (2015)

Wharton’s jelly-derived mesenchymal stem cells combined with praziquantel as a potential therapy for Schistosoma mansoni-induced liver fibrosis
por: Hammam, Olfat A., et al.
Publicado: (2016)

Co-administration of metformin and N-acetylcysteine with dietary control improves the biochemical and histological manifestations in rats with non-alcoholic fatty liver
por: El-Lakkany, Naglaa Mohamed, et al.
Publicado: (2016)

Evaluation of Artesunate and Praziquantel Combination Therapy in Murine Schistosomiasis mansoni
por: HEGAZY, Laila Abdel Moniem, et al.
Publicado: (2018)

Corrigendum: Wharton’s jelly-derived mesenchymal stem cells combined with praziquantel as a potential therapy for Schistosoma mansoni-induced liver fibrosis
por: Hammam, Olfat A., et al.
Publicado: (2016)

Praziquantel-encapsulated niosomes against Schistosoma mansoni with reduced sensitivity to praziquantel
por: Amer, Eglal I., et al.
Publicado: (2022)

Evaluation of the Anti-schistosomal Effects of Turmeric (Curcuma longa) Versus Praziquantel in Schistosoma mansoni Infected Mice
por: HUSSEIN, Atef, et al.
Publicado: (2017)

Free Radical-Scavenging, Anti-Inflammatory/Anti-Fibrotic and Hepatoprotective Actions of Taurine and Silymarin against CCl(4) Induced Rat Liver Damage
por: Abdel-Moneim, Ashraf M., et al.
Publicado: (2015)

Eugenol, a potential schistosomicidal agent with anti-inflammatory and antifibrotic effects against Schistosoma mansoni, induced liver pathology [Corrigendum]
Publicado: (2019)

Antifibrotic effects of gallic acid on hepatic stellate cells: In vitro and in vivo mechanistic study
por: El-Lakkany, Naglaa M., et al.
Publicado: (2018)

Comparative Molluscicidal and Schistosomicidal Potentiality of Two Solanum Species and Its Isolated Glycoalkaloids
por: Alsherbiny, Muhammad A., et al.
Publicado: (2018)

Praziquantel–lipid nanocapsules: an oral nanotherapeutic with potential Schistosoma mansoni tegumental targeting
por: Amara, Rokaya O, et al.
Publicado: (2018)

Schistosomicidal Activity of the Essential Oil of Ageratum conyzoides L. (Asteraceae) against Adult Schistosoma mansoni Worms
por: de Melo, Nathalya I., et al.
Publicado: (2011)

THE SUSCEPTIBILITY OF RECENT ISOLATES OF Schistosoma mansoni TO PRAZIQUANTEL
por: MENDONÇA, Adriana Maria B., et al.
Publicado: (2016)

In vivo assessment of the antischistosomal activity of curcumin loaded nanoparticles versus praziquantel in the treatment of Schistosoma mansoni
por: Mokbel, Kamal El-Din M., et al.
Publicado: (2020)

Possible carcinogenic potential of dimethyl dimethoxy biphenyl dicarboxylate in experimental animals
por: Botros, Sanaa Sabet, et al.
Publicado: (2016)

Resveratrol mitigates hepatic injury in rats by regulating oxidative stress, nuclear factor-kappa B, and apoptosis
por: Seif el-Din, Sayed Hassan, et al.
Publicado: (2016)

Single oral fixed-dose praziquantel-miltefosine nanocombination for effective control of experimental schistosomiasis mansoni
por: Eissa, Maha M., et al.
Publicado: (2020)

Preparation and Evaluation of Silymarin-Loaded Solid Eutectic for Enhanced Anti-Inflammatory, Hepatoprotective Effect: In Vitro–In Vivo Prospect
por: Sherikar, Abdulla, et al.
Publicado: (2021)

Targeting silymarin for improved hepatoprotective activity through chitosan nanoparticles
por: Gupta, Swati, et al.
Publicado: (2014)

Ameliorative Effect of Bone Marrow-Derived Stem Cells on Injured Liver of Mice Infected with Schistosoma mansoni
por: El-Mahdi, Magda M., et al.
Publicado: (2014)

Ginger (Zingiber Officinale)-derived nanoparticles in Schistosoma mansoni infected mice: Hepatoprotective and enhancer of etiological treatment
por: Abd El Wahab, Wegdan M., et al.
Publicado: (2021)

Hepatoprotective and renoprotective effects of silymarin against salinomycin-induced toxicity in adult rabbits
por: Ghonaim, Ahmed H., et al.
Publicado: (2022)

The Role of Efflux Pumps in Schistosoma mansoni Praziquantel Resistant Phenotype
por: Pinto-Almeida, António, et al.
Publicado: (2015)

Investigations on the interplays between Schistosoma mansoni, praziquantel and the gut microbiome
por: Schneeberger, Pierre H. H., et al.
Publicado: (2018)

A single locus determines praziquantel response in Schistosoma mansoni
por: Chevalier, Frédéric D., et al.
Publicado: (2023)

Hepatoprotective activity of silymarin encapsulation against hepatic damage in albino rats
por: Mukhtar, Shanza, et al.
Publicado: (2021)

Hepatoprotective effects of silymarin in management of liver injury caused by tuberculosis treatment
por: Lee, Yeong Yeh, et al.
Publicado: (2023)

Hepatoprotective effects of silymarin on CCl(4)-induced hepatic damage in broiler chickens model
por: Baradaran, A., et al.
Publicado: (2019)

Telmisartan, an AT1 receptor blocker and a PPAR gamma activator, alleviates liver fibrosis induced experimentally by Schistosoma mansoni infection
por: Attia, Yasmeen M, et al.
Publicado: (2013)

Computer-Assisted Discovery of Alkaloids with Schistosomicidal Activity
por: de Menezes, Renata Priscila Barros, et al.
Publicado: (2022)

Phytosomes as a Plausible Nano-Delivery System for Enhanced Oral Bioavailability and Improved Hepatoprotective Activity of Silymarin
por: Shriram, Ravi Gundadka, et al.
Publicado: (2022)

Synergy of Omeprazole and Praziquantel In Vitro Treatment against Schistosoma mansoni Adult Worms
por: Almeida, Giulliana T., et al.
Publicado: (2015)

Praziquantel Treatment Decreases Schistosoma mansoni Genetic Diversity in Experimental Infections
por: Coeli, Regina, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_b8sae32d6f25kl0sot28oq70nf